GITNUX MARKETDATA REPORT 2024

Gonorrhea Statistics: Market Report & Data

Highlights: Gonorrhea Statistics

  • In 2018, more than 580,000 gonorrhea cases were reported in the U.S alone.
  • Gonorrhea's rate in the general population is about 106 per 100,000 people as of 2018.
  • Gonorrhea has increased by 56% over the past decade in the U.S.
  • Gonorrhea is most common among people aged 15-24.
  • Men who have sex with men account for 70% of gonorrhea diagnoses in the U.S.
  • Gonorrhea can increase the risk of getting or transmitting HIV.
  • In 2013, Africa had the highest estimated incidence of gonorrhea at 40 cases per 1,000 men and 38.4 cases per 1,000 women.
  • In 2016, over 80% of new gonorrhea diagnoses in Europe were among people under the age of 30.
  • It's estimated that around 30%–50% of women with gonorrhea have no symptoms.
  • In 35% of countries, the last line treatment for gonorrhea is less effective due to drug resistance globally.
  • Only 51% of people in the U.S diagnosed with gonorrhea in 2016 were also tested for HIV.
  • Oropharyngeal gonorrhea has become increasingly prevalent, making up 15% of all gonorrhea infections in the United States in 2016.
  • Each year, nearly 78 million people are infected with gonorrhea worldwide.
  • The U.K. had a 26% increase in gonorrhea cases from 2018 to 2019.
  • There were 368.4 cases of gonorrhea per 100,000 people in Louisiana, the highest rate in any U.S. state as of 2020.
  • Alaska has the second highest gonorrhea incidence per 100,000 people in the U.S. as of 2020.
  • Australian men were three times more likely than women to have gonorrhea in 2019.
  • In 2020, one out of five gonorrhea cases in Australia were amongst people between 15-19 years old.
  • In 2020, men who have sex with men account for nearly 41% of all new diagnoses of gonorrhea in Greece.
  • Native Americans and Alaskan Natives have the highest rate of Gonorrhea infection among all ethic groups in the U.S., at 464.7 per 100,000 people in 2018.

Our Newsletter

The Business Week In Data

Sign up for our newsletter and become the navigator of tomorrow's trends. Equip your strategy with unparalleled insights!

Table of Contents

In this blog post, we’ll delve into an increasing public health concern of global significance – Gonorrhea. By unpacking a trove of statistical data, our aim is to unmask the magnitude, distribution, trend, and risk factors associated with this sexually transmitted infection (STI). Statistics pertaining to Gonorrhea provide a critical platform for understanding the prevalence, incidence and impact of this infection, ultimately empowering healthcare professionals, policymakers, and the public to implement effective strategies for prevention, treatment, and control. Let this statistical journey provide an insight into the invisible battle against Gonorrhea and shed light on the path forward.

The Latest Gonorrhea Statistics Unveiled

In 2018, more than 580,000 gonorrhea cases were reported in the U.S alone.

Highlighting the sheer scale of the health challenge, unveiling the stark figure of over 580,000 gonorrhea cases reported in the U.S in 2018 alone injects a sense of urgency and gravity into the discussion. This staggering number underscores the widespread nature of the sexually transmitted disease, driving home the reality of its prevalence, and propelling readers to acknowledge and understand the critical importance of protective measures, early diagnosis, and effective treatment plans. Such insight, therefore, serves as a potent wake-up call, energizing ongoing efforts to combat gonorrhea and reinforcing the significant public health implications of this pervasive issue.

Gonorrhea’s rate in the general population is about 106 per 100,000 people as of 2018.

Finely examining the prevalence rate of about 106 gonorrhea cases per 100,000 people as of 2018 reveals a crucial public health narrative. This figure serves as a stark reminder of gonorrhea’s pervasive grip on our society, underpinning the continued necessity for vigilant prevention strategies, educational outreach, and rigorous research efforts. In a blog post about Gonorrhea Statistics, this number becomes an authoritative lens through which we can gain a deeper understanding of the disease’s broader impact, from identifying vulnerable demographics, to charting the trajectory of infection rates, and to informing essential policy decisions to combat its spread effectively.

Gonorrhea has increased by 56% over the past decade in the U.S.

In the orbit of Gonorrhea statistics, the startling surge of 56% over the past decade in the U.S. paints a concerning picture as it underscores an urgent and escalating public health crisis. This revelation illuminates the importance of instituting preventative healthcare measures, enhancing awareness campaigns, and improving diagnostic facilities. It also illustrates the salient role of regular surveillance in tracking the disease and making inferences about infectious disease trends. Altogether, it is an impetus for healthcare stakeholders to ramp up efforts in battling this rampant sexualy transmitted infection.

Gonorrhea is most common among people aged 15-24.

Unveiling a pivotal highlight from the realm of Gonorrhea statistics, it’s intriguing to note the substantial concentration of this infection among young adults, primarily those aged 15-24. This revelation not only signifies an immediate alert for this age group but also signals imperative socio-health implications, like the need for effective sexual health education, early diagnosis, and prevention strategies. Thus, this statistic plays a cardinal role in shaping our recognition of Gonorrhea’s demographic profile, encouraging a targeted approach to combat this globally prevalent sexually transmitted infection within the pivotal blog post.

Men who have sex with men account for 70% of gonorrhea diagnoses in the U.S.

Illuminating the surprising hidden dimensions of the gonorrhea landscape, the assertion that “men who have sex with men account for 70% of gonorrhea diagnoses in the U.S.” from the recent data throws a spotlight on one of the crucial stress points in the fight against this STI. It draws our curiosity to the apparent disproportionality of the infection rate within this demographic, compelling us to explore the specific intersections of sexual behavior, biology and socio-environmental factors that could be at play here. With this revelation entwined in the discussion, the path to strategize targeted interventions becomes clearer, ultimately fostering a more comprehensive and nuanced understanding of Gonorrhea’s distribution and contributing to crafting policies for it’s management in the public health sphere.

Gonorrhea can increase the risk of getting or transmitting HIV.

Highlighting the correlation between Gonorrhea and HIV transmission could serve as a wake-up call for readers, underscoring the potential ripple effects of a Gonorrhea infection. In the arena of sexually transmitted diseases, understanding co-infection risks such as this can direct precautionary measures, help inform healthcare strategies, and may even encourage more conscientious sexual health practices. This key detail enriches the post by offering insight into the broader implications of Gonorrhea beyond its immediate symptoms, contributing to a more holistic understanding of the disease.

In 2013, Africa had the highest estimated incidence of gonorrhea at 40 cases per 1,000 men and 38.4 cases per 1,000 women.

Throwing light on the alarming incidence of gonorrhea in 2013, Africa took the lead with an estimated 40 cases in every 1,000 men and 38.4 cases in every 1,000 women. This startling statistic serves as a linchpin in our understanding of geographical trends in gonorrhea rates, and the urgent need for intensified public health interventions. By highlighting the continent where the battle is hardest fought, it punctuates strategic health planning and underscores the importance of targeted, localized prevention and treatment plans. Furthermore, it is a strong reminder of the disparities in sexual health and access to care that persist across the globe, making it a critical part of any discourse on Gonorrhea Statistics.

In 2016, over 80% of new gonorrhea diagnoses in Europe were among people under the age of 30.

Highlighting the figure ‘[In 2016, over 80% of new gonorrhea diagnoses in Europe were among people under the age of 30]’ paints a stark picture of the alarming prevalence of gonorrhea among young adults across the continent. It not only underscores the importance of early detection, prevention education, and aggressive treatment plans for this demographic but also helps guide policy-making and public health strategies towards effective interventions. The chilling detail implores a wide engagement and magnifies the necessity for the prioritization of sexual health especially in this vulnerable age group in Europe to curb the menacing incidence rate of this sexually transmitted disease.

It’s estimated that around 30%–50% of women with gonorrhea have no symptoms.

Navigating through the labyrinths of Gonorrhea Statistics unfurls a surprising revelation; an estimated 30%-50% of women infected with gonorrhea are clandestine carriers, bearing no symptoms. A number that not only uncovers the stealthy nature of the disease but also underscores the significance of regular screenings in the fight against one of the most common sexually transmitted infections. After all, discovery supports prevention, and knowing the odds is the first step towards initiating a successful public health dialogue and intervention. Statistics like this can help raise awareness, influence social behaviors, and ultimately, shift the tide in the battle against Gonorrhea.

In 35% of countries, the last line treatment for gonorrhea is less effective due to drug resistance globally.

Highlighting that “35% of countries globally report reduced efficacy in the last-line treatment for gonorrhea due to drug resistance” serves as a stark wake-up call in our blog post on Gonorrhea Statistics. It underscores the escalating threat of antibiotic resistance, contributing to potential catastrophic outcomes if neglected. By contextualizing this statistic, we illustrate a world where common infections, such as gonorrhea, can once again become uncontrollable. This gives our readers a sense of urgency, magnifying importance of continuous research, innovative treatment strategies, and adequate public health infrastructures to combat gonorrhea effectively.

Only 51% of people in the U.S diagnosed with gonorrhea in 2016 were also tested for HIV.

In the realm of Gonorrhea statistics, the figure that only 51% of individuals diagnosed with this STI in the U.S in 2016 were concurrently tested for HIV generates a significant point of concern. It underlines an alarming gap in comprehensive public health screening for sexually transmitted infections, revealing the potential missed opportunities for early HIV detection and subsequent treatment. Given the known correlation between these two conditions, this statistic emphasizes the urgent need for integrated testing strategies, promoting the idea that gonorrhea diagnosis should also trigger an automatic HIV check, which is not yet a widespread practice as the data suggests. Thus, ignoring this interaction could lead to an underestimation of HIV cases, hindering effective STI management and prevention efforts.

Oropharyngeal gonorrhea has become increasingly prevalent, making up 15% of all gonorrhea infections in the United States in 2016.

In unraveling the complexities of Gonorrhea Statistics, the surge of Oropharyngeal gonorrhea prevalence to 15% of all gonorrhea infections in the United States in 2016 places an enlightening spotlight. This striking shift underscores the mutating landscape of sexually transmitted infections, raising alarms for public health authorities. It highlights the necessity for more comprehensive screening and treatment approaches, specifically targeting the often overlooked oropharyngeal site. Moreover, this growing trend serves as a stark reminder for education efforts to stress safe sexual practices, including oral sex, as it elucidates the broader and often overlooked transmission avenues of gonorrhea.

Each year, nearly 78 million people are infected with gonorrhea worldwide.

Highlighting the bracing figure of nearly 78 million people contracting gonorrhea annually worldwide underscores the pervasive nature of this sexual infection and its global concern. This enormity not only provides perspective about the ubiquity of the ailment but also underscore the imperative need for sustained awareness, prevention efforts, and effective treatment protocols. Most crucially, it provides a clarion call to both policy makers and the general public to engage in concerted actions geared towards reducing this alarmingly high infection rate.

The U.K. had a 26% increase in gonorrhea cases from 2018 to 2019.

Unfolding the canvas of Gonorrhea Statistics in the U.K., an attention-grabbing rise of 26% in cases was documented from 2018 to 2019. This trend, far from just a cluster of dry numbers, is a significant pulse on public health, revealing a progressive spread of this sexually transmitted infection. The uptick throws a spotlight on an urgent need for reinforcement of preventive strategies, public awareness and testing measures. Thus, this staggering jump underscores the dynamic challenge of managing Gonorrhea, making it a focal point in an ongoing dialogue about sexually transmitted diseases.

There were 368.4 cases of gonorrhea per 100,000 people in Louisiana, the highest rate in any U.S. state as of 2020.

Casting a spotlight on Louisiana’s staggering gonorrhea rate, with a noteworthy standing of 368.4 cases per 100,000 residents in 2020, exposes the magnitude of this public health challenge in the United States. This peak prevalence, the highest in any state, serves as a critical barometer of the overall federated response to sexually transmitted infections, as well as a focal point for identifying socio-economic and behavioral factors contributing to the spread. Highlighting such paramount figures in a blog post about Gonorrhea Statistics could prompt further study, public awareness, and interventions to tilt the scale towards a reduced incidence of the disease.

Alaska has the second highest gonorrhea incidence per 100,000 people in the U.S. as of 2020.

Highlighting the state of affairs in Alaska serves as a sharp reminder to our readers about the pervasiveness and geographic discrimination of gonorrhea. As the state grapples with the silver medal in gonorrhea incidence per 100,000 people in 2020, we get a stern warning about the menacing prevalence of the disease, especially in less populated areas. This particular statistic drives home the need for comprehensive sexual education, early detection, and appropriate medical care regardless of one’s place of residence. Illuminating this gravity, Alaska’s scenario resonates the urgent call to action for all stakeholders involved in public health, making it an alarming focal point in our gonorrhea statistics discussion.

Australian men were three times more likely than women to have gonorrhea in 2019.

In the quest to fully decipher the prevalence and behavior of gonorrhea within a societal context, the distinction of infection rates by gender presents a pivotal cornerstone. The revelation that Australian men were thrice as likely as women to contract gonorrhea in 2019 casts a spotlight on the differential susceptibility or behavior by gender and compels critical examination. In unearthing the underpinnings of this disparity, we can enhance preventative measures, refine health education tactics, and better target treatment strategies, forming a crucial piece of the puzzle in the broader narrative of gonorrhea statistics.

In 2020, one out of five gonorrhea cases in Australia were amongst people between 15-19 years old.

Looking deeply into the compelling 2020 data on gonorrhea cases in Australia, one notices that a significant 20% of these cases registered were amidst individuals aged between 15 to 19 years. In the narrative of gonorrhea incidence, this nugget of information is vital as it sheds light on an unexpected age group — teenagers, often thought to have lower risk factors — being notably affected by this sexually transmitted disease. It warrants the need for targeted health protocols, awareness campaigns and educational initiatives, in a bid to curb the spread among this demographic, suggesting that prevention strategies need to be reevaluated and more youth-focused.

In 2020, men who have sex with men account for nearly 41% of all new diagnoses of gonorrhea in Greece.

Starkly reflected in the city of Athens and rippling across the olive groves of Greece, a conundrum emerges from the intersect of sexuality and disease prevalence. Through the lens of 2020, men who have sex with men constituted an alarmingly high proportion of new gonorrhea cases, nearly 41% to be exact. Consequently, this revelation becomes more than a mere statistic, it morphs into an urgent appeal for targeted awareness campaigns, sex education, and preventative measures within this community. Our exploration of gonorrhea statistics undoubtedly highlights this population, lifting the veil from a substantial infection reservoir, as these numbers reveal vulnerability, spurring actionable public health strategies.

Native Americans and Alaskan Natives have the highest rate of Gonorrhea infection among all ethic groups in the U.S., at 464.7 per 100,000 people in 2018.

Highlighting the alarming rate of Gonorrhea infection among Native Americans and Alaskan Natives at 464.7 per 100,000 people in 2018 provides a vital focal point in our discussion on Gonorrhea Statistics. It unveils an inequity in both healthcare provisions and awareness around STIs, predominantly among marginalized ethnic groups in the U.S. This data point not only urges the need for tailor-made preventive strategies and interventions to curb the disease but also underscores the larger discourse on health disparities among different ethnic groups in the U.S, making it integral to our blog post on Gonorrhea Statistics.

Conclusion

The statistics on gonorrhea serve as a significant reminder about the prevalent risk of sexually transmitted diseases. They underline the critical need for regular screenings, particularly amongst sexually active individuals and high-risk groups and particularly in light of the emerging antibiotic-resistant strains. It is hoped that these insights spur health organizations and individuals towards more preventative measures, improved treatments, and ultimately, a decline in gonorrhea cases globally.

References

0. – https://www.www.bbc.com

1. – https://www.eody.gov.gr

2. – https://www.www.aihw.gov.au

3. – https://www.www.cdc.gov

4. – https://www.www.ncbi.nlm.nih.gov

5. – https://www.www.who.int

6. – https://www.www.womenshealth.gov

7. – https://www.www.statista.com

8. – https://www.www.ecdc.europa.eu

FAQs

What is Gonorrhea?

Gonorrhea, also known as "the clap," is a sexually transmitted disease (STD) caused by the bacterium Neisseria gonorrhoeae. This bacterium tends to infect warm, moist areas of the body, including the urethra, eyes, throat, vagina, anus, female reproductive tract, and, in babies, the eyes.

How common is Gonorrhea?

Gonorrhea is a very common infectious disease. Each year worldwide, there are an estimated 78 million new cases of gonorrhea among adults.

What are the symptoms of Gonorrhea?

Most men with gonorrhea exhibit symptoms such as burning during urination and discharge from the penis. However, infected women are frequently asymptomatic or exhibit symptoms (i.e., pain during urination, increased vaginal discharge, or vaginal bleeding between periods) that are often mild and can be mistaken for a bladder or vaginal infection.

How is Gonorrhea diagnosed?

Gonorrhea can be diagnosed either through a urine test or a more direct swab of the affected area. A sample of the discharge from the penis or the cervix can be taken and the specimen is cultured in a laboratory for the presence of N. gonorrhoeae.

Can Gonorrhea be cured?

Yes, gonorrhea can be cured with the right medication. The CDC currently recommends dual therapy (i.e., using two drugs) for the treatment of gonorrhea, such as using an injectable cephalosporin and oral azithromycin.

How we write our statistic reports:

We have not conducted any studies ourselves. Our article provides a summary of all the statistics and studies available at the time of writing. We are solely presenting a summary, not expressing our own opinion. We have collected all statistics within our internal database. In some cases, we use Artificial Intelligence for formulating the statistics. The articles are updated regularly.

See our Editorial Process.

Table of Contents

... Before You Leave, Catch This! 🔥

Your next business insight is just a subscription away. Our newsletter The Week in Data delivers the freshest statistics and trends directly to you. Stay informed, stay ahead—subscribe now.

Sign up for our newsletter and become the navigator of tomorrow's trends. Equip your strategy with unparalleled insights!